One World Pharma(OWPC)
$0.000.00 (0.00%)
OWPC
One World Pharma financials statements
$0.00
At close:0.00 (0.00%)
One World Pharma (OWPC) Ratios
21 Followers
One World Pharma Ratios
OWPC's free cash flow for Q3 2025 was $166.68K. For the 2025 fiscal year, OWPC's free cash flow was increased by $3.00 and operating cash flow was $-145.00K. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.02 | 0.00 | 0.04 | 0.33 | 0.25 |
| Quick Ratio | 0.02 | 0.00 | 0.02 | 0.20 | 0.09 |
| Cash Ratio | 0.01 | 0.00 | 0.00 | 0.08 | 0.02 |
| Solvency Ratio | -0.39 | -1.01 | -0.72 | -2.17 | -4.24 |
| Operating Cash Flow Ratio | -0.35 | -0.31 | -0.46 | -2.45 | -0.84 |
| Short-Term Operating Cash Flow Coverage | -0.67 | -0.54 | -1.28 | -8.17 | -3.76 |
| Net Current Asset Value | $ -9.91M | $ -3.86M | $ -4.10M | $ -1.23M | $ -1.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 54.95 | 22.32 | 0.76 | 0.23 | 0.41 |
| Debt-to-Equity Ratio | -0.38 | -0.59 | -2.29 | 0.56 | -1.29 |
| Debt-to-Capital Ratio | -0.61 | -1.41 | 1.77 | 0.36 | 4.46 |
| Long-Term Debt-to-Capital Ratio | -0.27 | 0.00 | -5.94 | 0.14 | 0.00 |
| Financial Leverage Ratio | -0.01 | -0.03 | -3.01 | 2.46 | -3.12 |
| Debt Service Coverage Ratio | -0.61 | -1.43 | -1.08 | -3.34 | -18.43 |
| Interest Coverage Ratio | -1.71 | -6.74 | -2.34 | -6.32 | -166.36 |
| Debt to Market Cap | 1.46 | 0.77 | 0.37 | 0.13 | 0.06 |
| Interest Debt Per Share | 0.05 | 0.03 | 0.05 | 0.02 | 0.01 |
| Net Debt to EBITDA | -2.21 | -0.61 | -1.09 | -0.17 | -0.07 |
| Profitability Margins | |||||
| Gross Profit Margin | 80.51% | -2181.22% | -139.34% | 48.40% | -75.81% |
| EBIT Margin | -35204.48% | -48024.51% | -1673.23% | -8554.87% | -13291.65% |
| EBITDA Margin | -34499.86% | -47572.99% | -1745.04% | -8449.48% | -13235.22% |
| Operating Profit Margin | -38494.63% | -27419.57% | -1779.48% | -8444.76% | -13291.65% |
| Pretax Profit Margin | -80917.38% | -52092.78% | -2434.69% | -9890.66% | -13371.54% |
| Net Profit Margin | -80917.38% | -52092.78% | -2434.69% | -9890.66% | -13371.54% |
| Continuous Operations Profit Margin | -80917.38% | -52092.78% | -2434.69% | -9890.66% | -13371.54% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 210.20% | 189.98% | 136.82% | 117.12% | 100.60% |
| Return on Assets (ROA) | -5761.36% | -3998.02% | -96.58% | -130.36% | -565.88% |
| Return on Equity (ROE) | 39.70% | 104.77% | 290.99% | -320.84% | 1765.68% |
| Return on Capital Employed (ROCE) | 60.38% | 55.15% | -1175.23% | -234.22% | 2685.24% |
| Return on Invested Capital (ROIC) | 130.57% | 132.89% | -164.69% | -191.31% | -6065.80% |
| Return on Tangible Assets | -5761.36% | -3998.02% | -96.58% | -130.36% | -565.88% |
| Earnings Yield | -152.64% | -137.17% | -57.78% | -76.16% | -135.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.38 | 1.90 | 10.17 | 0.29 | 0.57 |
| Payables Turnover | 0.00 | 0.33 | 0.38 | 0.04 | 0.14 |
| Inventory Turnover | 0.06 | 0.00 | 5.55 | 0.10 | 0.39 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.09 | 0.04 | 0.06 |
| Asset Turnover | 0.07 | 0.08 | 0.04 | 0.01 | 0.04 |
| Working Capital Turnover Ratio | -0.00 | -0.00 | -0.06 | -0.03 | -0.06 |
| Cash Conversion Cycle | -222394.58 | -922.47 | -866.93 | -3966.00 | -983.63 |
| Days of Sales Outstanding | 83.31 | 192.10 | 35.89 | 1238.92 | 645.35 |
| Days of Inventory Outstanding | 6247.35 | 0.00 | 65.72 | 3671.35 | 931.07 |
| Days of Payables Outstanding | 228725.25 | 1114.56 | 968.54 | 8876.28 | 2560.06 |
| Operating Cycle | 6330.67 | 192.10 | 101.61 | 4910.28 | 1576.42 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.06 | -0.03 |
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.07 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -8.31 | -236.65 | -31.95 | -8.20 | -14.32 |
| Capital Expenditure Coverage Ratio | -14.96 | -236.65 | -31.95 | -9.48 | -22.84 |
| Operating Cash Flow Coverage Ratio | -0.30 | -0.54 | -0.57 | -5.68 | -2.46 |
| Operating Cash Flow to Sales Ratio | -230.65 | -157.35 | -10.99 | -97.45 | -23.99 |
| Free Cash Flow Yield | -46.42% | -41.61% | -26.89% | -82.95% | -25.46% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.65 | -0.73 | -1.73 | -1.31 | -0.74 |
| Price-to-Sales (P/S) Ratio | 530.13 | 379.77 | 42.14 | 129.87 | 98.37 |
| Price-to-Book (P/B) Ratio | -0.26 | -0.76 | -5.04 | 4.21 | -12.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.15 | -2.40 | -3.72 | -1.21 | -3.93 |
| Price-to-Operating Cash Flow Ratio | -2.30 | -2.41 | -3.84 | -1.33 | -4.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.04 | 0.07 | 0.02 | 0.00 |
| Enterprise Value Multiple | -3.75 | -1.41 | -3.51 | -1.70 | -0.81 |
| Enterprise Value | 6.29M | 5.09M | 7.69M | 5.51M | 6.41M |
| EV to EBITDA | -3.75 | -1.41 | -3.51 | -1.70 | -0.81 |
| EV to Sales | 1293.17 | 670.54 | 61.22 | 143.90 | 107.65 |
| EV to Free Cash Flow | -5.26 | -4.24 | -5.40 | -1.34 | -4.30 |
| EV to Operating Cash Flow | -5.61 | -4.26 | -5.57 | -1.48 | -4.49 |
| Tangible Book Value Per Share | -0.09 | -0.05 | -0.02 | 0.02 | -0.01 |
| Shareholders’ Equity Per Share | -0.09 | -0.05 | -0.02 | 0.02 | -0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.04 | -0.05 | -0.05 | -0.06 | -0.16 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 2.30 | 1.08 | 1.46 | 1.16 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 352.85 | 247.87 | 16.06 | 83.88 | 131.59 |
| Stock-Based Compensation to Revenue | 243.36 | 54.71 | 2.70 | 3.50 | 60.07 |
| Income Quality | 0.29 | 0.30 | 0.45 | 0.99 | 0.18 |
Currency in USD
